Control, n (%) | Intervention, n (%) | OR^{a} (P) | Adjusted OR^{b} (95% CI) | |||
---|---|---|---|---|---|---|

Baseline | Month 6 | Baseline | Month 6 | |||

Vaccine hesitant, % | ||||||

PACV^{c} | ||||||

50–100 | 25 (12.6) | 14 (8.0) | 19 (9.8)^{d} | 13 (7.5) | 0.93 (.78) | 1.22^{e} (0.47–2.68)^{f} |

Vaccine hesitant, ordinal | ||||||

PACV^{g} | ||||||

0–29^{h} | 140 (70.7) | 139 (79.9) | 144 (74.6)^{i} | 138 (79.8) | 0.95 (.86) | 1.13 (0.61–2.10)^{j} |

30–49 | 33 (16.7) | 21 (12.1) | 30 (15.5) | 22 (12.7) | ||

50–59 | 15 (7.6) | 6 (3.4) | 13 (6.7) | 8 (4.6) | ||

60–69 | 5 (2.5) | 4 (2.3) | 3 (1.6) | 2 (1.2) | ||

70+ | 5 (2.5) | 4 (2.3) | 3 (1.6) | 3 (1.7) |

↵

^{a}OR for difference in month 6 hesitancy between intervention and control groups.↵

^{b}Adjusted for baseline PACV hesitancy score and race (2 indicator variables for white, Asian, and all other races).↵

^{c}PACV, score 50–100. Estimated with GEE logistic regression with empirical SEs.↵

^{d}OR for baseline difference between groups 0.76 (*P*= .43) (Table 1).↵

^{e}OR >1.0 corresponds to a higher hesitancy rate in the intervention group.↵

^{f}*P*= .71↵

^{g}Proportional odds regression with mixed effects to account for within-clinic correlation. ORs estimate the odds of being at a higher hesitancy category.↵

^{h}PACV, scores 0–100 where 100 is most hesitant; ≥50 indicates vaccine hesitancy.↵

^{i}OR for baseline difference between groups: 0.78 (*P*= .42).↵

^{j}*P*= .60.